Zacks Research Weighs in on Deciphera Pharmaceuticals, Inc.'s Q1 2025 Earnings (NASDAQ:DCPH) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) – Equities researchers at Zacks Research issued their FY2026 earnings per share estimates for Deciphera Pharmaceuticals in a research report issued on Tuesday, February 27th. Zacks Research analyst A. Chakraborty anticipates that the company will post earnings of ($1.25) per share for the year. The consensus estimate for […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) – Research analysts at HC Wainwright raised their Q1 2024 EPS estimates for Deciphera Pharmaceuticals in a report issued on Wednesday, February 7th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings of ($0.63) per share for the quarter, up from their previous estimate […]
Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have issued a buy rating on the […]